- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05625321
Stepping Into Lifestyle Changes (SILC)
Community-Based Strategies to Reduce Cardiometabolic Disease in the Deep South
Study Overview
Status
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Alabama
-
Birmingham, Alabama, United States, 35294
- The University of Alabama at Birmingham
-
-
Mississippi
-
Jackson, Mississippi, United States, 39216
- The University of Mississippi Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- self-identifies as Black and/or African American
- ≥ 30 years old
- a measured BMI >25 kg/m2 and at least one other cardiometabolic risk factor (physician diagnosis of pre-diabetes and/or hypertension within past 2 years)
- lives, works, or worships in one of the 12 intervention communities and expresses no intentions to move outside of that community in the 18 months following enrollment
- a willingness to participate in the study for the 18-months duration.
Exclusion Criteria:
- being or planning to become pregnant during the 18-month study duration
- a baseline blood pressure and/or glucose that is outside of the normal range and a medical provider does not provide clearance to participate
- medical contraindications
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Educational Group Weight Loss Classes
Participants will participate in a 12-month weight loss program, taught by lay health educators, and designed to promote and encourage healthy weight loss, dietary changes, and increased physical activity.
Participants will attend 90-minute sessions weekly for 6 months, bi-weekly for 3 months, and monthly for 3 months.
|
Participants will be provided with educational materials on weight loss, and have opportunities to increase their exercise and make changes to their diet.
|
|
Experimental: Educational Group Weight Loss Classes PLUS Home Gardening Intervention
Participants will receive the educational group weight loss classes PLUS a home gardening intervention.
The gardening intervention will be led by local Master Gardeners (MGs) who will help guide participants in setting-up and maintaining their garden.
|
Participants will be provided with educational materials on weight loss, and have opportunities to increase their exercise and make changes to their diet.
Participants will receive tools to establish their own home garden, increasing their access to fresh fruits and vegetables.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Weight
Time Frame: 0, 6, and 12 months
|
Changes in Weight, measured in pounds
|
0, 6, and 12 months
|
|
BMI
Time Frame: 0, 6, and 12 months
|
Changes in BMI, calculated as a person's weight in kilograms divided by the square of height in meters
|
0, 6, and 12 months
|
|
Waist Circumference
Time Frame: 0, 6, and 12 months
|
Changes in waist circumference, measured in centimeters
|
0, 6, and 12 months
|
|
Dietary Intake
Time Frame: 0, 6, and 12 months
|
Changes in diet, measured using a questionnaire
|
0, 6, and 12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Diastolic and Systolic Blood Pressure
Time Frame: 0, 6, and 12 months
|
Changes in values over time, using a calibrated automatic sphygmomanometer and following NHLBI protocols
|
0, 6, and 12 months
|
|
Fasting Glucose
Time Frame: 0, 6, and 12 months
|
Changes in glucose readings, collected by finger-stick
|
0, 6, and 12 months
|
|
Cholesterol Levels
Time Frame: 0, 6, and 12 months
|
Changes in LDL and HDL values/ratio, collected by finger-stick
|
0, 6, and 12 months
|
|
Physical Activity
Time Frame: 0, 6, and 12 months
|
Changes in physical activity, measured by the International Physical Activity Questionnaire (IPAQ). For the IPAQ survey, participants will be asked to indicate if they have completed low (sitting or walking) levels of activity, moderate levels of activity, and/or high levels of activity in the last 7 days.They will also be asked to provide the number of days they do each activity and the time, in minutes, they spend doing the activity. |
0, 6, and 12 months
|
|
Physical Activity
Time Frame: 0, 6, and 12 months
|
Changes in physical activity, measured by the Stanford Leisure Time Activity Categorical Item (L-cat). The L-Cat is categorical and responses range from 1-6 with 1 indicating little to no physical activity, and 6 indicating vigorous activity for 5 or more days a week. |
0, 6, and 12 months
|
|
Perceived Quality of Life
Time Frame: 0, 6, and 12 months
|
Changes in Quality of Life as measured by the EuroQol-5 Dimension survey (EQ-5D-5L).
Condition states range from 1-5 with 1 meaning the participant has no problems or symptoms and 5 meaning they have are unable to perform the activity or are extremely impacted by the condition.
Self reported health is measured on a 1 to 100 scale with 1 being the worst possible health and 100 being the best possible health.
|
0, 6, and 12 months
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Monica Baskin, PhD, University of Alabama at Birmingham
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 300009477
- P50MD017338 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Overweight and Obesity
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Institut Investigacio Sanitaria Pere VirgiliCompletedObesity, Childhood | Overweight and Obesity | Overweight, ChildhoodSpain
-
Holbaek SygehusUniversity of Copenhagen; University of Florida; University of Minnesota; Hebrew... and other collaboratorsRecruitingChildhood Overweight and ObesityDenmark
-
National University Health System, SingaporeActive, not recruitingObesity | Overweight and/or Obesity | Overweight or Obese Adults | Overweight , ObesitySingapore
-
National Taiwan University HospitalCompleted
-
PfizerNot yet recruitingObesity | Overnutrition | Nutrition Disorders | Overweight | Body Weight | Overweight or Obesity | Overweight and/or Obesity | Nutritional and Metabolic DiseasesUnited States
-
University of Texas Southwestern Medical CenterChildren's Medical Center DallasRecruitingPediatric Obesity | Pediatric Overweight | Overweight , ObesityUnited States
-
Universidade do Extremo Sul Catarinense - Unidade...RecruitingObesity | Overweight and Obesity | Obesity; Endocrine | Overweight, Obesity and Other HyperalimentationBrazil
-
Mexican National Institute of Public HealthUNICEFCompleted
-
Universidade do PortoFundação para a Ciência e a Tecnologia; Administração Regional de Saúde do... and other collaboratorsCompletedOverweight and ObesityPortugal
Clinical Trials on Educational Group Weight Loss Classes
-
University of FloridaNational Institute on Aging (NIA)Completed
-
University of OklahomaTerminatedObesity | Bariatric Surgery Candidate | Endometrial CancerUnited States
-
Dana-Farber Cancer InstituteCompletedWeight Loss Program After Cancer DiagnosisUnited States
-
Kaiser PermanenteUniversity of Minnesota; Oregon Research InstituteCompleted
-
University of Kansas Medical CenterAmerican Cancer Society, Inc.CompletedObesity | Prostate CancerUnited States
-
Million Marker Wellness, Inc.Mayo Clinic; National Institute of Environmental Health Sciences (NIEHS)Active, not recruitingEnvironmental Exposure | Overweight (BMI > 25) | Obesity &Amp;Amp;Amp; OverweightUnited States
-
VA Office of Research and DevelopmentCompleted
-
The Miriam HospitalNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingObesity/therapyUnited States